2023年2月27日月曜日

Caretaker LVET byIphone2 19Jan22 MRI試験検査用 被権者のバイタルサインを遠隔監視表示できる ケアテイカ タイプ4をご案内

ケアテイカ タイプ4は、MRI下の被験者の生体データお解析して連続に出力いますーメディカルテクニカ

ケアテイカタイプ4 MRI試験検査用 被権者のバイタルサインを遠隔監視表示できる ケアテイカ タイプ4をご案内

MRI試験検査用 被権者のバイタルサインを遠隔監視表示できる ケアテイカタイプ4のご案内2020年10月版 10Oct20

MRI試験検査用 被権者のバイタルサインを遠隔監視表示できる ケアテイカ出荷前検査中

西陣心電布ー 12誘導心電図用 従来の 高価な銀塩化銀を使用したディスポの電極にとって代わるー布製のテクノセンサーがラブテック ホルタで綺麗に...

西陣心電布ー京都大学と帝人が開発したー 12誘導心電図用 従来の 高価な銀塩化銀を使用したディスポの電極にとって代わるー布製のテクノセンサーをご...

2023年2月25日土曜日

急性心筋梗塞発症を救いたい ウエアラブル着衣式電極の利用が診療報酬・保険適用になった

ウエアラブル・着衣式 12誘導心電図電極を用いた心疾患や睡眠時無呼吸などの診断法 ウエアラブル着衣式電極の利用が診療報酬・保険適用になった

Holter presentation Usage ウエアラブル着衣式電極の利用が診療報酬・保険適用になった

帝人フロンティアブースーウエアラブル展2018 保険適用になった

Topic of Meiji Times 日本の明治

クラウド カーディオロジ モバイル 12誘導心電図 送受信システム wavelet algorithm メディカルテクニカ

第41回日本生理心理学会 2023年5月20日21日開催に参考展示させて頂く予定です

第41回日本生理心理学会 2023年5月20日21日開催に参考展示させて頂く予定です

Caretaker LVET byIphone2 第41回日本生理心理学会 2023年5月20日21日開催に参考展示させて頂く予定です

研究用ーケアテイカ  第41回日本生理心理学会 2023年5月20日21日開催に参考展示させて頂く予定です

ケアテイカ出荷前検査中 第41回日本生理心理学会 2023年5月20日21日開催に参考展示させて頂く予定です

ケアテイカタイプ4のご案内 第41回日本生理心理学会 2023年5月20日21日開催に参考展示させて頂く予定です

2023年2月9日木曜日

Caretaker Experimental type has been used for fMRI study

Using Physiological MRI to Estimate Dynamic Cerebral Autoregulation Metrics Functional MRI Feasibility Study Negar Hawezi 30/04/2015 1 Contents 1.1 Background ............................................................................................. 15 1.2 Physiological aspects of Cerebral Autoregulation........................................... 18 2.1 Introduction............................................................................................. 47 2 2.2 Methods .................................................................................................. 49 2.3 Results.................................................................................................... 51 2.4 Methods to quantify CA metrics .................................................................. 54 2.4.1 Magnetic resonance imaging (MRI) studies............................................. 54 2.4.2 Trans-cranial Doppler ultrasound studies (TCD) ...................................... 58 2.5 Cerebral autoregulation indices .................................................................. 60 2.6 Discussion ............................................................................................... 64 2.6.1 Non invasive physiological method to measure CA .................................. 64 2.6.2 Consistency of CA metrics .................................................................... 65 2.6.3 Regional heterogeneity ........................................................................ 66 2.6.4 Interventions to fluctuate blood pressure ............................................... 69 2.6.5 Limitations ......................................................................................... 72 2.7 Conclusions and future directions ............................................................... 74 3 Obtaining beat-to-beat Arterial Blood Pressure Measurements using Non invasive methods ............................................................................................................ 75 3.1 Background ............................................................................................. 75 3.2 Plethysmographic arterial blood pressure recording devices ........................... 78 3.2.1 MR compatible arterial blood pressure monitoring device (NIBPMRI/Caretaker; Biopac®) ............................................................................... 78 3.2.2 Non invasive Continuous Arterial Blood Pressure Monitoring Device from (Finometer ®)............................................................................................... 79 3.2.3 Technical issues .................................................................................. 82 3.3 Monitoring beat-to-beat arterial blood pressure measures ............................. 83 3 3.3.1 Methods and materials......................................................................... 83 4.5.1 Thigh –cuff release............................................................................ 125 4.5.2 Inspiratory breath-hold method iBH .................................................... 128 4.5.3 Statistical analysis............................................................................... 131 4.6 Discussion ............................................................................................. 133 4.7 Limitations............................................................................................. 137 Table of Figures Figure 1 Classic cerebral autoregulation curve [32]........................................................................................22 Figure 2 Circle of Willis (CoW), Time of Flight Angiography (ToF)...................................................................25 Figure 3 Chart of search results (PRISMA statement) .......................................................................53 Figure 4Methods to simulate dynamic cerebral auto regulation....................................................................57 Figure 5 Summary of non invasive BP fluctuation methods ...........................................................................77 Figure 6 Caretaker finger cuff, port and graphical user interface GUI.............................................................81 Figure 7 Finometer finger cuff and device......................................................................................................81 Figure 8:Schematic representation of cued deep breathing test (CDB) and observed BP response. ...............87 Figure 9: Blood pressure (BP) response curve to thigh-cuff release (TCR) method .........................................91 Figure 10 Mean arterial blood pressure (MAP) from Caretaker device ..........................................................97 Figure 11 :Sequential representation (from left to right) of iBH protocol instruction slides.........................111 Figure 12: Watershed areas segmentation...................................................................................................115 Figure 13: Thigh-cuff release test (TCR) in the scanner.................................................................................119 Figure 14: Breath-hold test (modeling different variables) ..........................................................................120 Figure 15 Reactivity analysis of brain, for iBH challenge (23 years, male subject) ........................................130 Figure 16 Bland-Altman plots.......................................................................................................................132 Figure 17 Graphical representation of the relationship between CBF and PaCO2 [131]. ..............................136 Figure 18: 4D PC MRI data analysis from GT-flow ........................................................................................145 Figure 19: Average flow velocity ..................................................................................................................148 Figure 20 Flow curve through three different arteries .................................................................................149 Figure 21: Peak systolic and end diastolic velocities ....................................................................................150 Figure 22 Mean arterial blood pressure (MAP) during BH and iBH protocols...............................................155 6 Table of Tables Table 1 Summary of the autoregulation indices used to estimate dCA .........................................................63 Table2 Summary of the volunteers who participated in each protocol. TCR, Thigh-cuff release, iBH, deepinspiratory breath-hold test. BH, non-inspiratory breath-hold test. CDB, cued deep-breathing. BOLD, Blood oxygen level dependent MRI, 4D PC, Time resolved Phase-contrast MR angiography..................86 Table 3: Mean arterial blood pressure measures (MAP) at the baseline from the three devices (Omron-HEM, Caretaker, and Finometer) .....................................................................................................................92 Table 4 MAP measures from the Caretaker and Finometer devices at different time points after cuffdeflation .....................92 Table 12 Flow velocity for two subjects at averaged 20 phases of cardiac cycle time points. At baseline, at 33% inspiratory breath-hold (iBH), and at 33% non-inspiratory breath-hold (BH)................................151 7 Abstract Cerebral autoregulation is the homeostatic mechanism that maintains sufficient cerebral circulation despite changes in the perfusion pressure. Dynamic CA refers to the changes that occur in CBF within the first few seconds after an acute MAP change. Assessment of the CA impairment plays important role in the prognosis of many cerebrovascular diseases such as stroke, sub-arachnoid haemorrhage, as well as traumatic brain injury and neurodegenerative disorders. This thesis investigates the feasibility of using physiological MRI to estimate dynamic cerebral autoregulation (dCA) metrics. In particular, this thesis has an emphasis on measuring beat-to-beat arterial blood pressure inside the scanner to provide better understanding of the physiological aspects of dCA. Further, continuous blood pressure (BP) measures in response to different non invasive BP fluctuating methods are acquired to evaluate the reliability of these methods to induce response changes. Blood Oxygen Level Dependent (BOLD) fMRI method was used to estimate the expected variations of tissue oxygenation during induced dCA changes in healthy volunteers. The non invasive arterial blood pressure measurements were acquired using MR compatible arterial blood pressure monitoring device (NIBP-MRI/Caretaker; Biopac®). Further, sudden release of inflated thigh-cuffs (TCR) and inspiratory breath-hold (iBH) methods were used in the scanner to induce dynamic autoregulatory changes. These two methods were investigated in a pilot study, to evaluate the reliability prior to the MR study by comparing BP measurements obtained outside the scanner using non invasive methods. This pilot study included monitoring BP changes in response to four types of non invasive BP fluctuating methods. The reliability of NIBP/MRI Caretaker device was examined by comparing the BP response changes with the simultaneously acquired BP data from Finometer plethysmographic device. The cerebral autoregulation metrics were estimated 8 by calculating the rate of regulation (RoR) following dynamic BP fluctuating events. Rate of regulation defines the rate at which the BOLD signal changes depending on MAP changes at a particular time. Further, the tissue specific regulation parameters were obtained for grey matter (GM), white matter (WM) and water shed areas (WS). The effect of iBH method on cerebral blood flow (CBF) and velocity (CBFV) was explored in a preliminary study by quantitative measures using time resolved 4D PC MRI angiography in two subjects. The mean arterial blood pressure (MAP) changes in response to TCR and iBH method were comparable. The fMRI data demonstrated BOLD signal amplitude change in response to the induced fast MAP changes. The GM and WS areas showed similar rates of regulation, and these were nominally higher than WM RoR in both TCR and iBH methods. Further, the 4D PC MRI data suggested 29% CBF-increase in response to 33% iBH in four minutes acquisition time. The acquired non invasive arterial BP measures concurrent with the BOLD signal amplitude response, allowed deriving the rate of regulation as a metric of dCA. It is not known whether this information is clinically relevant to gauge the haemodynamic risk association to cerebrovascular disease. However, BOLD signal change and CBF changes after iBH are confounded by the extent to which the CO2 gradually accumulate in response to iBH and causes an overshoot in the CBF response-change. In conclusion, the presented study indicates the feasibility of using physiological MRI to measure dCA in response to non-invasively induced MAP changes. Estimation of the dCA metrics could be improved by using advanced data fitting methods as well as controlling for physiological parameters such as PECO2. 9 Declaration I hereby declare that this thesis is my own work and effort

信州の茂田井宿など